Investorideas.com - Cannabis-infused beverages could help to retain young beer drinkers, says GlobalData
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Tuesday, November 28, 2017
(CSE: $VRT.C), (OTC: $VRTHF) News: US Patent Office Acknowledges Provisional Patent Application for Use of Specific #Cannabis Strain to Enhance Opioid Analgesia
(CSE: $VRT.C), (OTC: $VRTHF) News: US Patent Office Acknowledges
Provisional Patent Application for Use of Specific #Cannabis Strain to Enhance
Opioid Analgesia
Patent Filed by Veritas’ Research
Arm Cannevert
November 28, 2017, Vancouver, B.C. – (Investorideas.com
Newswire) Veritas Pharma Inc.
(CSE: VRT; OTC:
VRTHF;
and Frankfurt: 2VP), (“Veritas” or the “Company”) announces its research arm,
Cannevert Therapeutics Ltd. (“CTL”) filed a provisional patent application to
US Patent and Trademark Office (the “USPTO”) on September 13, 2017 for use of a
specific cannabis strain to enhance the actions of opioid analgesics. An acknowledgement letter from the USPTO was
received recently which provided a filing number of US 62/558,021 for this
application.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/11281CannabisCSEVRT.asp
Opioids are substances that are derived from the opium
poppy plant. They bind to the human
body’s own opioid receptors to provide pain relief or ‘analgesia’ for patients
with acute or chronic pain when prescribed legally; morphine is an example
opioid analgesic. Use of these drugs for
a brief time is considered safe for pain management. However, when they are overprescribed
and/or frequently misused, they produce a sense of euphoria along with
relieving pain. Hence, drug dependence
can occur despite using them as prescribed over prolonged periods with the
potential of fatal overdose. Opioid
overdose contributed to more than 33,000 deaths in 2015 according to US Centers
for Disease Control and Prevention. Heroin and fentanyl are the most widely
known opioids for their illegal, recreational use, abuse potential and fatal
overdoses.
Cannabis contains substances called cannabinoids that appear to bind
to human body’s own cannabinoid receptors to also produce similar effects to those
of the body’s opioids in mediating analgesia and behavioral effects. However, they do not have the same drug
dependence or overdose potential. When
cannabinoids and opioids are combined, they appear to augment each other’s
effects synergistically. Therefore, the
combination may allow for opioids to be used at lower doses with fewer side
effects for the treatment of pain and related addiction. According Coherent
Market Insights*, the global opioids market was approximately USD $17b in
2015 and is forecasted to moderately increase to near USD $26b in 2024. It indicates that legal cannabis is expected
to impact the opioids market growth as it gets adopted as a safe alternative
pain relieving therapy to opioids and it is increasingly being used to address related
addiction. According to the World Drug Report 2016, approximately 17 million
people suffered from opioid drug abuse.
Veritas CEO, Dr. Lui Franciosi stated, “We are pleased with Cannevert’s latest
submission to protect its discovery of a cannabis strain that could potentially
reduce the dose and side effects of clinically used opioids while maintaining a
good pain relieving effect for patients.”
Dr. Franciosi goes on to say, “This strain could be also potentially
useful in addressing the current fentanyl crisis throughout North America. If we’re targeting pain or opioid addiction,
we want to deliver a scientifically tested, standardized product that
clinicians can rely upon.”
Also, to note, the Company will be issuing 1.1 million stock options
based on today’s closing price of CAN$0.81 cents.
*Global Opioids Agonist Drugs Market, By Product Type (Codeine,
Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone), Therapeutic
Application (Pain Management, Cough Treatment, Diarrhea Treatment), and
Geography - Trends, Analysis and Forecast till 2024 (Market Report – March 2017)
About Veritas Pharma Inc.
Veritas Pharma Inc. is an emerging-stage pharmaceutical
and IP development company, who, through its 80% owned Cannevert Therapeutics
Ltd. ("CTL"), is advancing the science behind medical cannabis. It is
the Company aim, through its investment in CTL, to develop the most effective
cannabis strains (cultivars) specific to pain, nausea, epilepsy and PTSD,
solving the critical need for clinical data to support medical marijuana
claims. CTL’s unique value proposition uses a low-cost research and development
model to help drive shareholder value, and speed-to-market. Veritas investment
in CTL is led by strong management team, bringing together veteran academic
pharmacologists, anesthetists & chemists. The company's commercial mission
is to patent protect CTL’s IP (cultivars & strains) and sell or license to
cancer clinics, insurance industry and pharma, targeting multi-billion dollar
global markets.
Veritas Pharma Inc. is a publicly traded company which
trades in three countries including Canada, on the Canadian Stock Exchange
under the ticker VRT; in the United States, on the OTC under the ticker VRTHF;
and in Germany, on the Frankfurt exchange under the ticker 2VP.
For more information, please visit our website: veritaspharmainc.com
On behalf
of the Board of Directors
"Dr. Lui Franciosi"
Dr. Lui Franciosi
President and Chief Executive Officer
Further information about the Company is available on
our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com and on the CSE website at www.thecse.com.
Investor
and Public Relations Contact
Veritas Pharma Inc.
Sam Eskandari
Telephone: +1.416.918.6785
The CSE has not reviewed, nor
approved or disapproved the content of this press release.
This news is published on the Investorideas.com
Newswire – News that Inspires big ideas Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of investment.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Contact each company
directly regarding content and press release questions. Disclosure is posted
for each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. More disclaimer info:
http://www.investorideas.com/About/Disclaimer.asp. Disclosure this news is a
paid for news release on the Investorideas.com newswire by
Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF) Learn more about costs and our newswire service http://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global
Investors: Effective September 15 2008 - all BC investors should review all OTC
and Pink sheet listed companies for adherence in new disclosure filings and
filing appropriate documents with Sedar. Read for more info:
http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to
regulations of each country.
At Cannabisinvestorideas.com and Investorideas.com
Monday, November 27, 2017
#ICO Alert: One Cryptocurrency Platform is Pioneering a new Paradigm That Could Change Everything!
#ICO Alert: One Cryptocurrency Platform is Pioneering a new Paradigm
That Could Change Everything!
November 27, 2017 (Investorideas.com Newswire)
On the early morning of June 19, 2016, Travis Mason, a guard at a marijuana dispensary in Aurora,
Colorado, was fatally shot in the head by two armed
robbers. These men weren't looking for pot; they were searching for what they
must have suspected were substantial amounts of cash kept at the dispensary. This was born out by the heist of
$100,000 in cash from a dispensary in Seattle a year earlier.
"This incredibly sad situation underscores the public safety risk faced by
our industry due to the fact that we don't have access to banking,"
Michael Elliott, executive director of the Marijuana Industry Group, told the
Aurora Sentinel.
Read
this news in full at http://www.investorideas.com/news/2017/bitcoin/11275CryptocurrencyICO.asp
He is correct. In Canada and especially in the
US, very few banks will have anything to do with cash generated from the sale
of marijuana or cannabis-based products because they are illegal at the federal
level. This has caused huge and potentially fatal headaches for pot stores and dispensaries as they attempt to conduct
an all-cash business - from sales to payroll to taxes.
Though there is hope on the horizon for
Canadian businesses as a bill for national legalization is expected to be
tabled soon, for US businesses the nightmare is only beginning as more and more
states vote to legalize pot for recreational use yet it remains federally
illegal.
While security companies and business owners
work to make the industry more secure, the only circumstances that will truly
change the plight of these operations would be if and when they are afforded
the same financial protections as other businesses. This could be decades away
if business owners are forced to wait for their national banking system to
provide these protections. Fortunately, Cryptocurrency is coming to the rescue.
What Is CannaSOS?
In 2014, CannaSOS launched as an amalgamation
of a social network, advertising platform and marijuana database with plans to
eventually incorporate a complete Cryptocurrency transaction platform known as
the PerksCoin Transaction Platform, or PTP. This platform will enable cannabis
consumers, and the vendors, manufacturers and advertisers of cannabis-related
products, to exchange secure currency for products provided or services
rendered. In short, it stands to be the vehicle by which the cannabis community
can finally enjoy financial freedom and security worldwide. Today, the CannaSOS
site boasts over 315,000 registered members and 970 business pages.
The PerksCoin Transaction Platform
PTP is a Cryptocurrency platform set to run on
decentralized blockchain technology. Once launched, the platform will exist as
an autonomous entity regulated by the participants in the blockchain. The
platform will incorporate a cryptocurrency wallet and be free to use by the
public.
Features of the platform include:
- Operate on an autonomous utility token, the PerksCoin
Token (PCT);
- Generate and withdraw PerksCoin Tokens (PCT) from
circulation for token liquidity;
- Guarantee security, transparency, and safety of all
PCT-based transactions;
- Act as a mediator/arbitrator between Seller and Buyer;
- Support peer-to-peer PCT token sale, eliminating
middleman and associated costs;
- Offer Secure Sale feature to protect buyers from unverified
sellers, minimizing fraudulent activity in the marketplace;
The secure sale features will not be necessary
for small, over-the-counter transactions but will undoubtedly be coveted by
businesses for B2B operations for large sums pertaining to advertising,
inventory and supply purchases. Both consumers and businesses will likely elect
to utilize the Secure Sale system for their online transactions.
The rendering party will be responsible for
paying a service fee in PCT tokens. The fee amount will be determined based on
a vote by blockchain participants. PCT tokens collected as a payment for Secure
Sale service will be removed from the blockchain via burning.
Why CannaSOS?
According to California treasurer John Chiang,
the US cannabis industry is expected to blow passed the $7 billion mark in
2018. Meanwhile, an estimated 70% of these businesses do not have bank
accounts. In his words, "this is trouble waiting to happen."
Just ask the many business owners trying to do
the right thing in an industry in which the financial component resembles the
gold rush in the wild west. "We're close to a crisis when
it comes to how to manage the situation in legal fashion," said Kathleen
Van Osten, a consultant who represents a "regulatory-minded" San Jose
cannabis manufacturer. "They're running out of space to store cash."
Besides the personal risks to business owners
and employees, dealing with cash also cuts down on the profitability of
canna-related businesses.
Khurshid Khoja, an attorney for the California
Cannabis Industry Association, said one of his clients has 60 employees and an
accounting team of four, plus a controller - "nearly unheard of" for
a company that size. The firm pays $325,000 a year in salaries to people who
deal only with cash handling, and estimates it loses $1 million a year to the
various burdens cash imposes.
Meanwhile, consumers of cannabis-related
products are inconvenienced by the fact that very few businesses can allow them
to use debit or credit cards. Those who do typically need to charge a fee due
to the expense on their end.
There can be no doubt that the entire cannabis
industry is yearning for a financial transaction platform that addresses these
concerns, and PerksCoin tokens and the PTP created by CannaSOS are perfectly
positioned to do just that.
PerksCoin will also be used as a loyalty program
among retailers, wholesalers, and other businesses in not just the cannabis
industry. One example is Pundi X - a CannaSOS partner. CannaSOS universal API
for PerksCoin (to be created around April, 2018) will be implemented into Pundi
X's POS platform; which currently operates in 600~ locations in South East
Asia, and is planning on adding another 200,000 locations by 2020. Pundi X's
POS platform is currently implemented in restaurants and Café's, convenience
stores and other shops.
The CannaSOS ICO
CannaSOS enjoyed a spectacular pre-ICO with
upwards of 9 million PCT tokens being reserved up by over 400 early adopters.
With the public presale for the ICO starting on November 25, savvy
cryptocurrency watchers will have the opportunity to jump onboard what could be
a game-changer for the cannabis industry at
a substantial discount.
"The last month or so has been a
whirlwind as we've seen an intense outpouring of interest both on the
investment and implementation side," remarked CannaSOS founder and CEO
Oleg Cheine. "Clearly, both blockchain experts, as well as
cannabis-related experts and organizations, recognize the potential of our
transaction platform for the industry."
Learn more about CannaSOS and claim a slot in
the ICO public presale at: cannasos.com/crowdsale-ico
Bitcoin, Blockchain and Digital Currency
Stocks and ICO's
Like Bitcoin, Blockchain and Digital Currency
Stocks?
View our Bitcoin, Blockchain and Digital Currency Stocks Directory Get News Alerts on Bitcoin Stocks
Join our Crypto/blockchain group on
Linkedin
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher
of third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investment involves
risk and possible loss of investment. This site is currently compensated for
news publication and distribution, social media and marketing, content creation
and more. Contact each company directly regarding content and press release
questions. Disclosure is posted for each compensated news release, content
published /created if required but otherwise the news was not compensated for
and was published for the sole interest of our readers and followers. More
disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and
global Investors: Effective September 15 2008 - all BC investors should review
all OTC and Pink sheet listed companies for adherence in new disclosure filings
and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
Wednesday, November 22, 2017
Tuesday, November 21, 2017
Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis
Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)